Description
LH846 is an inhibitor of casein kinase 1δ (CK1δ) that also displays activity against CK1α and CK1ε. In research models, this compound lengthens the circadian period.
LH846 is an inhibitor of casein kinase 1δ (CK1δ) that also displays activity against CK1α and CK1ε. In research models, this compound lengthens the circadian period.
Cas No. | 639052-78-1 |
---|---|
Purity | ≥98% |
Formula | C16H13ClN2OS |
Formula Wt. | 316.80 |
IUPAC Name | N-(5-Chloro-6-methyl-1,3-benzothiazol-2-yl)-2-phenylacetamide |
Solubility | 100mM in DMSO |
Store Temp | -20°C |
---|---|
Ship Temp | Ambient |
MSDS | |
---|---|
Info Sheet |
Lee JW, Hirota T, Peters EC, et al. A small molecule modulates circadian rhythms through phosphorylation of the period protein. Angew Chem Int Ed Engl. 2011 Nov 4;50(45):10608-11. PMID: 21954091.
Calcium channel blocker.
Mycotoxin produced by Alternaria; topoisomerase...
Synthetic analog of 1,4-naphthoquinone, precurs...
β-lactamase inhibitor.
β1/2-adrenergic agonist.
Thiazolidinedione; PPARγ agonist.
MEK1/2 inhibitor.
IGF-1R and InsR inhibitor.
Furanolactone found in Citrus.
Kynurenine 3-hydroxylase inhibitor.
Alkylphospholipid analog; Akt inhibitor.
Endogenous neuropeptide hormone, lowers extrace...
STING antagonist
β1/2-adrenergic antagonist.
Synthesis impurity
β-adrenergic antagonist.
Isoleucyl-tRNA synthase inhibitor, osteoclast p...
Fluoroquinolone; topoisomerase IV and bacterial...
TLR4 inhibitor.